SBRA-31012(State University of New York/Roswell Park Cancer Institute)
N/A
Report date: 2022/12/07 16:54:36
Base Information
Drug NameSBRA-31012(State University of New York/Roswell Park Cancer Institute)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState University of New York at Stony BrookRoswell Park Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRoswell Park Cancer InstituteState University of New York at Stony Brook
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A